Cubicin(R) for Complicated Post-surgical Wound Infections
Clinical trial NCT00651131 · TERMINATED
Trial details
- NCT number
- NCT00651131
- Sponsor
- Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2004-06-01
- Primary completion
- 2005-03-01
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.